Maxcyte (MXCT) Research & Development (2020 - 2026)
Maxcyte (MXCT) reported Research & Development of $3.9 million for Q1 2026, down 34.66% year-over-year from $5.9 million in Q1 2025, and up 15.65% on a QoQ basis from $3.3 million in Q4 2025.
Maxcyte (MXCT) has 7 years of Research & Development data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Research & Development fell 34.66% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.8 million (down 12.47% YoY) and the FY2025 annual result came in at $20.8 million, down 6.32% from the prior year.
- Research & Development grew to $3.9 million in Q1 2026 per MXCT's latest filing, from $3.3 million in the prior quarter.
- Across five years, Research & Development topped out at $6.7 million in Q1 2024 and bottomed at $3.3 million in Q4 2025.
- The 5-year median for Research & Development is $5.6 million (2024), against an average of $5.3 million.
- Peak annual rise in Research & Development reached 93.86% in 2022, while the deepest fall reached 38.03% in 2022.
- Tracing MXCT's Research & Development over 5 years: stood at $5.7 million in 2022, then grew by 2.0% to $5.8 million in 2023, then fell by 21.02% to $4.6 million in 2024, then dropped by 27.72% to $3.3 million in 2025, then increased by 15.65% to $3.9 million in 2026.
- Per Business Quant, the three latest MXCT Research & Development figures stand at $3.9 million (Q1 2026), $3.3 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 5.90 Mn |
| Dec 31, 2024 | 4.61 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 6.68 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Sep 30, 2023 | 6.26 Mn |
| Jun 30, 2023 | 5.66 Mn |
| Mar 31, 2023 | 6.05 Mn |
| Dec 31, 2022 | 5.73 Mn |
| Sep 30, 2022 | 5.33 Mn |
| Jun 30, 2022 | 4.70 Mn |
| Mar 31, 2022 | 3.77 Mn |
| Dec 31, 2021 | 3.38 Mn |
| Sep 30, 2021 | 2.75 Mn |
| Jun 30, 2021 | 3.20 Mn |
| Mar 31, 2021 | 6.08 Mn |
| Dec 31, 2020 | 4.88 Mn |
| Sep 30, 2020 | 4.52 Mn |
| Jun 30, 2020 | 4.09 Mn |